Literature DB >> 23425996

Transient spreading and swelling behavior of a gel deploying an anti-HIV topical microbicide.

Savas Tasoglu1, David F Katz, Andrew J Szeri.   

Abstract

Drug delivery of topical microbicidal molecules against HIV offers promise as a modality to prevent sexual transmission of the virus. Success of any microbicide product depends, in an interactive way, upon its drug (the microbicide active pharmaceutical ingredient, API) and its delivery system (e.g. a gel, film or intravaginal ring). There is a widespread agreement that more effective drug delivery vehicles, as well as better APIs, must be developed to improve the efficacy of microbicide products. Non-Newtonian gels are primary microbicide vehicles, but those to date have been created with limited understanding of how their properties govern their spreading and retention in the vagina, which, in turn, govern successful drug delivery. Here, we apply fundamental fluid mechanical and physicochemical transport theory to help better understand how successful microbicide API delivery depends upon properties of a gel and the vaginal environment. We address several critical components of this complex process, including: elastohydrodynamic flow of the bolus of a non-Newtonian fluid; and mass transfer due to inhomogeneous dilution of the gel by vaginal fluid contacting it along a moving boundary (the locally deforming vaginal epithelial surface). Local dilution of gel alters local rheological properties. We evaluated this experimentally, delin-eating the way that constitutive parameters of a shear-thinning gel are modified by dilution. We supplement the Reynolds lubrication equation with a mass conservation equation to model diluting fluid movement across the moving vaginal epithelial surface and into the gel bolus. This is a physicochemically complex phenomenon that is not well understood. We implement a boundary flux model based upon the elevated hydrodynamic pressures in the cells. Results show that this model produces fluxes that lie within the range of mean values that have been reported. Further experimental characterization of the vaginal wall is required for a more precise set of parameters and a more sophisticated theoretical treatment of epithelium.

Entities:  

Keywords:  Anti-HIV microbicide; Imbibition; Lubrication flow; Squeezing flow; Swelling

Year:  2012        PMID: 23425996      PMCID: PMC3575089          DOI: 10.1016/j.jnnfm.2012.08.008

Source DB:  PubMed          Journal:  J Nonnewton Fluid Mech        ISSN: 0377-0257            Impact factor:   2.670


  22 in total

Review 1.  A vaginal fluid simulant.

Authors:  D H Owen; D F Katz
Journal:  Contraception       Date:  1999-02       Impact factor: 3.375

Review 2.  Intravaginal gels as drug delivery systems.

Authors:  Mary Justin-Temu; Festo Damian; Renaat Kinget; Guy Van Den Mooter
Journal:  J Womens Health (Larchmt)       Date:  2004-09       Impact factor: 2.681

3.  Design of a semisolid vaginal microbicide gel by relating composition to properties and performance.

Authors:  Alamelu Mahalingam; Eric Smith; Judit Fabian; Festo R Damian; Jennifer J Peters; Meredith R Clark; David R Friend; David F Katz; Patrick F Kiser
Journal:  Pharm Res       Date:  2010-09-15       Impact factor: 4.200

4.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

5.  A model of transluminal flow of an anti-HIV microbicide vehicle: Combined elastic squeezing and gravitational sliding.

Authors:  Andrew J Szeri; Su Chan Park; Stéphane Verguet; Aaron Weiss; David F Katz
Journal:  Phys Fluids (1994)       Date:  2008-08-21       Impact factor: 3.521

6.  Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection.

Authors:  Anthony S Ham; Shweta R Ugaonkar; Lianjun Shi; Karen Watson Buckheit; Howard Lakougna; Umadevi Nagaraja; Garry Gwozdz; Laurie Goldman; Patrick F Kiser; Robert W Buckheit
Journal:  J Pharm Sci       Date:  2012-01-06       Impact factor: 3.534

7.  Interpreting properties of microbicide drug delivery gels: analyzing deployment kinetics due to squeezing.

Authors:  Sarah L Kieweg; David F Katz
Journal:  J Pharm Sci       Date:  2007-04       Impact factor: 3.534

8.  Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1.

Authors:  Alamelu Mahalingam; Adam P Simmons; Shweta R Ugaonkar; Karen M Watson; Charlene S Dezzutti; Lisa C Rohan; Robert W Buckheit; Patrick F Kiser
Journal:  Antimicrob Agents Chemother       Date:  2011-01-18       Impact factor: 5.191

9.  In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide.

Authors:  Lisa C Rohan; Bernard J Moncla; Ratiya Pamela Kunjara Na Ayudhya; Marilyn Cost; Yunda Huang; Fang Gai; Nicole Billitto; J D Lynam; Kara Pryke; Phillip Graebing; Nicole Hopkins; James F Rooney; David Friend; Charlene S Dezzutti
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

Review 10.  Nanomedicines for ocular NSAIDs: safety on drug delivery.

Authors:  Joana Araújo; Elisabet Gonzalez; Maria Antonia Egea; Marisa Luisa Garcia; Eliana B Souto
Journal:  Nanomedicine       Date:  2009-03-31       Impact factor: 5.307

View more
  13 in total

1.  Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.

Authors:  Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Sara Vargas; Julia G Shaw; E Milu Kojic; Patrick F Kiser; David R Friend; David F Katz
Journal:  AIDS Res Hum Retroviruses       Date:  2013-12-09       Impact factor: 2.205

Review 2.  Vaginal drug distribution modeling.

Authors:  David F Katz; Andrew Yuan; Yajing Gao
Journal:  Adv Drug Deliv Rev       Date:  2015-04-28       Impact factor: 15.470

3.  Coupled gel spreading and diffusive transport models describing microbicidal drug delivery.

Authors:  Claire Funke; Kelsey MacMillan; Anthony Ham; Andrew J Szeri; David F Katz
Journal:  Chem Eng Sci       Date:  2016-05-12       Impact factor: 4.311

4.  Transient swelling, spreading, and drug delivery by a dissolved anti-HIV microbicide-bearing film.

Authors:  Savas Tasoglu; Lisa C Rohan; David F Katz; Andrew J Szeri
Journal:  Phys Fluids (1994)       Date:  2013-03-04       Impact factor: 3.521

5.  Gravity-Driven Thin Film Flow of an Ellis Fluid.

Authors:  Vitaly O Kheyfets; Sarah L Kieweg
Journal:  J Nonnewton Fluid Mech       Date:  2013-12-01       Impact factor: 2.670

6.  Olive oil based novel thermo-reversible emulsion hydrogels for controlled delivery applications.

Authors:  Vinay K Singh; Sowmya Ramesh; Kunal Pal; Arfat Anis; Dillip K Pradhan; Krishna Pramanik
Journal:  J Mater Sci Mater Med       Date:  2013-12-11       Impact factor: 3.896

7.  Experimental and numerical models of three-dimensional gravity-driven flow of shear-thinning polymer solutions used in vaginal delivery of microbicides.

Authors:  Vitaly O Kheyfets; Sarah L Kieweg
Journal:  J Biomech Eng       Date:  2013-06       Impact factor: 2.097

8.  Pharmacokinetic and Pharmacodynamic Evaluation following Vaginal Application of IQB3002, a Dual-Chamber Microbicide Gel Containing the Nonnucleoside Reverse Transcriptase Inhibitor IQP-0528 in Rhesus Macaques.

Authors:  Lara E Pereira; Pedro M M Mesquita; Anthony Ham; Tyana Singletary; Frank Deyounks; Amy Martin; Janet McNicholl; Karen W Buckheit; Robert W Buckheit; James M Smith
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

Review 9.  Manipulating biological agents and cells in micro-scale volumes for applications in medicine.

Authors:  Savas Tasoglu; Umut Atakan Gurkan; Shuqi Wang; Utkan Demirci
Journal:  Chem Soc Rev       Date:  2013-07-07       Impact factor: 54.564

10.  Multicompartmental pharmacokinetic model of tenofovir delivery by a vaginal gel.

Authors:  Yajing Gao; David F Katz
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.